Abbott Wins Nod for 14 Day Version of Freestyle Libre

Abbott Wins Nod for 14 Day Version of Freestyle Libre

Source: 
Medical Devices and Diagnostics Industry
snippet: 

Abbott Laboratories has received FDA approval of the Freestyle Libre 14 Day Flash Glucose Monitoring System (CGM). FDA’s nod of the Abbott, IL-based company’s device follows on the heels of the 2017 approval of the 10 Day Freestyle Libre CGM in the U.S.